PIK3CA mutation in ER-negative and HER2-positive breast cancer with apocrine differentiation

Breast Cancer 2026

View at publisher
Authors: Fumi Nozaki, Yoko Nakanishi, Yukari Hirotani, Hiroko Kobayashi, Tomoyuki Tanino, Haruna Nishimaki-Watanabe, Sumie Ohni, Xiaoyan Tang, Shinobu Masuda
DOI: 10.1007/s12282-026-01837-4
Cited by: 1
References: 12

Fields of Study & Subjects

PI3K/AKT/mTOR signaling in cancer Breast Lesions and Carcinomas Genetic Syndromes and Imprinting

Publication details

Journal / source
Breast Cancer
Publisher
Springer Science and Business Media LLC
Volume
33
Issue
3
Pages
625–633
Publication date
23 February 2026
Language
EN